US 11,766,431 · Application 17/245,209 · Granted Sep 26, 2023
US 11,766,431
New therapeutical composition containing apomorphine as active ingredient
Estimated expiration
July 11, 2032
5y 286d remaining
- Could not fetch continuity data for application PCTEP2012002916: Resource not found (404)
Earliest effective filing
Jul 11, 2012
+ 20 years
Jul 11, 2032
PTA +213d
Feb 9, 2033
TD cap (US 11,026,938)
Jul 11, 2032
Final
Jul 11, 2032
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- April 30, 2021
- Earliest effective filing
- July 11, 2012
- Issue date
- September 26, 2023
- PTA
- +213 days
- Base expiry (before PTA)
- July 11, 2032
July 11, 2012 + 20 years = July 11, 2032 + 213 PTA days = February 9, 2033
- Continuation of application 14/152,000, filed Jan 10, 2014, issued as US 11,026,938
- Continuation of application PCTEP2012002916, filed Jul 11, 2012
- Continuation of application PCTEP2012002916, filed Jul 11, 2012
Terminal disclaimers
TD caps expiration to July 11, 2032 (earliest expiring referenced patent: US 11,026,938)
US 11,026,938· Application 14/152,000Capping patent
New therapeutical composition containing apomorphine as active ingredient
- Filing date
- Jan 10, 2014
- Earliest effective filing
- Jul 11, 2012
- Issue date
- Jun 8, 2021
- PTA
- 0 days
- Calculated expiration
- Jul 11, 2032
Continuation of PCTEP2012002916, filed Jul 11, 2012
Jul 11, 2012 + 20y = Jul 11, 2032
US 11,766,431· Application 17/245,209(from application 17/245,209)
New therapeutical composition containing apomorphine as active ingredient
- Filing date
- Apr 30, 2021
- Earliest effective filing
- Jul 11, 2012
- Issue date
- Sep 26, 2023
- PTA
- +213 days
- Calculated expiration
- Feb 9, 2033
Continuation of 14/152,000, filed Jan 10, 2014, issued as US 11,026,938
Continuation of PCTEP2012002916, filed Jul 11, 2012
Continuation of PCTEP2012002916, filed Jul 11, 2012
Jul 11, 2012 + 20y + 213d PTA = Feb 9, 2033
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/245,209 · US 11,766,431
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,766,431: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11766431Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.